TENX Tenax Therapeutics, Inc.

Fundamentals / CIK 0000034956 / USD

Tenax Therapeutics, Inc. reported $0 in revenue and a net loss of $65.76M for the trailing twelve months ended September 30, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TENX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$16.44M$8.22M$0-$50.12MFY 2016 Revenue: $0FY 2016 Net Income: -$43.92M2016FY 2017 Net Income: -$8.84M2017FY 2018 Net Income: -$14.14M2018FY 2019 Net Income: -$8.39M2019FY 2020 Net Income: -$9.85M2020FY 2021 Net Income: -$32.47M2021FY 2022 Net Income: $11.05M2022FY 2023 Net Income: -$7.71M2023FY 2024 Revenue: $0FY 2024 Net Income: -$17.60M2024FY 2025 Revenue: $0FY 2025 Net Income: -$52.60M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 -- -- -- -- -- -- -- $0
Cost of Revenue -- -- -- -- -- -- -- -- -- $0
Gross Profit -- -- -- -- -- -- -- -- -- $0
Research & Development $32.67M $12.71M $3.23M $5.38M $25.15M $4.56M $3.47M $1.24M $3.53M $13.14M
Selling, General & Admin -- -- -- -- $7.58M $5.31M $5.08M $5.65M $5.68M $6.25M
Total Operating Expenses $56.38M $19.49M $8.23M $11.05M $32.73M $9.87M $8.56M $6.89M $9.21M $52.65M
Operating Income -$56.38M -$19.49M -$8.23M $11.05M -$32.73M $9.87M -$8.56M -$6.89M -$9.21M -$52.65M
EBITDA -- -$19.49M -$8.23M $11.06M -$32.72M $9.87M -$8.55M -$6.88M -$9.19M -$52.63M
Interest Expense $0 $23K $24K $4.4K $949 $1.6K $0 -- -- $0
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 -$7.96M
Net Income -$52.60M -$17.60M -$7.71M $11.05M -$32.47M -$9.85M -$8.39M -$14.14M -$8.84M -$43.92M
Basic EPS -$1.34 -$1.15 -$31.04 -- -$1.58 -$0.95 -$1.35 -$9.04 -$6.27 -$31.24
Diluted EPS -$1.34 -$1.15 -$31.04 -- -$1.58 -$0.95 -$1.35 -$9.04 -$6.27 -$31.24
Basic Shares Outstanding 39.2M 15.3M 248.4K -- 20.6M 10.4M 6.2M 1.6M 1.4M 1.4M
Diluted Shares Outstanding 39.2M 15.3M 248.4K -- 20.6M 10.4M 6.2M 1.6M 1.4M 1.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $0 $0 $0 $0 --
Research & Development $12.07M $12.85M $11.54M $10.54M $10.33M $6.12M $5.68M $4.59M
Selling, General & Admin $5.66M $5.93M -- -- $6.48M $5.67M -- --
Total Operating Expenses $17.73M $18.78M $16.57M $16.45M $16.81M $11.79M $11.34M $7.29M
Operating Income -$17.73M -$18.78M -$16.57M -$16.45M -$16.81M -$11.79M -$11.34M -$7.29M
EBITDA -- -- -- -- -- -- -- -$7.29M
Interest Expense -- -- -- $0 $0 $0 $0 -$1.0K
Net Income -$16.70M -$17.80M -$15.72M -$15.54M -$15.80M -$10.85M -$10.41M -$6.27M
Basic EPS -$0.31 -$0.35 -$0.35 -- -$0.40 -$0.27 -$0.28 --
Diluted EPS -$0.31 -$0.35 -$0.35 -- -$0.40 -$0.27 -$0.28 --
Basic Shares Outstanding 53.5M 50.9M 45.2M -- 39.7M 39.6M 36.6M --
Diluted Shares Outstanding 53.5M 50.9M 45.2M -- 39.7M 39.6M 36.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $97.60M $94.90M $9.80M $2.12M $5.58M $6.25M $4.91M $12.37M $1.60M $10.00M
Short-Term Investments -- -- -- -- $0 $463K $494K $495K $6.12M $3.28M
Cash & Short-Term Investments $97.60M $94.90M $9.80M $2.12M $5.58M $6.71M $5.40M $12.86M $7.73M $13.28M
Accounts Receivable, Net -- -- -- -- -- -- -- $0 $50K $73K
Other Current Assets $1.02M $64K $252K $346K $0 -- -- -- -- --
Total Current Assets $104.2M $96.69M $11.68M $3.21M $5.69M $6.80M $6.18M $13.32M $8.06M $13.63M
Property, Plant & Equipment, Net -- -- $0 $7.2K $7.1K $6.0K $6.6K $8.5K $9.9K $19K
Goodwill -- -- -- -- -- -- -- -- -- $0
Intangible Assets -- -- -- -- -- -- -- -- -- $0
Long-Term Investments -- -- -- -- -- -- $0 $0 $1.81M $8.59M
Other Non-Current Assets -- $0 $1.0K $9.6K $8.4K $8.4K $8.4K $8.4K $8.4K $1.11M
Total Non-Current Assets $0 $0 $1.0K $196K $303K $73K $184K $17K $1.83M $9.71M
Total Assets $104.2M $96.69M $11.69M $3.40M $5.99M $6.87M $6.37M $13.34M $9.89M $23.34M
Accounts Payable $6.04M $3.16M $2.07M $448K $860K $758K $1.66M $750K $612K $728K
Total Current Liabilities $7.16M $4.69M $3.59M $1.85M $1.56M $2.12M $2.53M $1.57M $1.01M $6.20M
Total Non-Current Liabilities $0 $0 $0 $64K $184K $124K $60K $0 $0 $0
Total Liabilities $7.16M $4.69M $3.59M $1.91M $1.75M $2.24M $2.59M $1.57M $1.01M $6.20M
Total Debt (incl. Leases) -- -- -- $184K $291K $60K $172K -- -- --
Common Stock $1.0K $0 $0 $3 $2.5K $0 $674 $379 $141 $2.8K
Retained Earnings -$367.5M -$314.9M -$297.3M -$289.5M -$278.5M -$246.0M -$236.2M -$227.8M -$213.5M -$204.7M
Accumulated Other Comp. Income -- -- -- -- $0 -$70 $458 $516 -$16K -$19K
Total Stockholders' Equity $97.07M $91.99M $8.10M $1.49M $4.24M $4.63M $3.77M $11.77M $8.88M $17.14M
Total Equity $97.07M $91.99M $8.10M $1.49M $4.24M $4.63M $3.77M $11.77M $8.88M $17.14M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $113.7M $118.0M $118.8M $97.60M $99.40M $105.5M $111.4M $94.90M
Cash & Short-Term Investments $113.7M $118.0M $118.8M $97.60M $99.40M $105.5M $111.4M $94.90M
Other Current Assets $108K $272K $107K $1.02M -- -- $88K $64K
Total Current Assets $117.0M $121.7M $123.2M $104.2M $102.8M $105.9M $112.1M $96.69M
Other Non-Current Assets -- -- -- -- -- -- -- $0
Total Non-Current Assets $0 $0 $0 $0 $0 $0 $0 $0
Total Assets $117.0M $121.7M $123.2M $104.2M $102.8M $105.9M $112.1M $96.69M
Accounts Payable $6.57M $6.79M $6.35M $6.04M $5.61M $562K $1.84M $3.16M
Total Current Liabilities $8.36M $8.07M $8.49M $7.16M $6.60M $2.53M $2.77M $4.69M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $8.36M $8.07M $8.49M $7.16M $6.60M $2.53M $2.77M $4.69M
Common Stock $5.0K $3.0K $2.0K $1.0K $1.0K $0 $0 $0
Retained Earnings -$417.7M -$401.0M -$383.2M -$367.5M -$351.9M -$336.1M -$325.3M -$314.9M
Total Stockholders' Equity $108.7M $113.6M $114.7M $97.07M $96.21M $103.3M $109.3M $91.99M
Total Equity $108.7M $113.6M $114.7M $97.07M $96.21M $103.3M $109.3M $91.99M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$52.60M -$17.60M -$7.71M -$11.05M -$32.47M $9.85M -$8.39M -$14.14M -$8.84M -$43.92M
Depreciation & Amortization -- $0 $8.0K $5.1K $4.1K $4.1K $5.0K $9.0K $14K $19K
Stock-Based Compensation $19.16M $1.12M $191K -- -- -- $0 $190K $80K $1.1K
Change in Inventory -- -- -- -- -- -- -- -- -- $0
Change in Payables $2.88M $1.06M $1.65M -- -- -- -- -- -- --
Operating Cash Flow -$35.80M -$14.81M -$5.90M -$11.39M -$10.86M -$9.27M -$7.56M -$5.50M -$12.14M -$15.87M
Capital Expenditure -- -- -- -$2.3K -$5.3K -$3.5K -$3.6K -$7.6K -$4.5K -$2.9K
Free Cash Flow -- -- -- -$11.39M -$10.86M -$9.28M -$7.56M -$5.51M -$12.15M -$15.87M
Purchases of Investments -- -- -- $0 -$346K -$597K -$618K -$494K -$299K -$7.26M
Investing Cash Flow -- $0 $3.0K -$2.3K $453K $20K -$1.7K $7.35M $3.75M $22.21M
Common Stock Issued -- -- -- -- $9.19M $8.66M $0 -- -- $0
Financing Cash Flow $38.51M $99.87M $13.57M $7.93M $9.74M $10.60M $96K $8.91M $0 $0
Net Change in Cash $2.71M $85.06M $7.67M -$3.46M -$666K $1.34M -$7.46M $10.76M -$8.39M $6.34M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$16.70M -$17.80M -$15.72M -$15.54M -$15.80M -$10.85M -$10.41M -$6.27M
Depreciation & Amortization -- -- -- -- -- -- -- $0
Stock-Based Compensation $3.54M $3.33M $2.84M $4.79M $5.62M $4.61M $4.14M $970K
Change in Payables -$225K $449K $305K $432K $5.05M -$1.28M -$1.32M $1.57M
Operating Cash Flow -$12.48M -$14.15M -$9.31M -$13.41M -$9.15M -$6.26M -$6.97M -$3.53M
Investing Cash Flow -- -- -- -- $0 $0 $0 $0
Financing Cash Flow $8.23M $13.37M $30.50M $11.61M $3.06M $278K $23.56M $67K
Net Change in Cash -$4.25M -$779K $21.19M -$1.80M -$6.09M -$5.99M $16.60M -$3.46M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -54.2% -19.1% -95.2% 740.0% -765.1% -213.0% -222.5% -120.2% -99.5% -256.3%
Return on Assets (ROA) -50.5% -18.2% -66.0% 324.5% -541.9% -143.4% -131.9% -106.0% -89.4% -188.2%
Current Ratio 14.56x 20.60x 3.26x 1.74x 3.64x 3.21x 2.44x 8.51x 7.99x 2.20x
Quick Ratio 13.64x 20.22x 2.73x 1.15x 3.57x 3.17x 2.13x 8.21x 7.71x 2.15x
Debt to Equity -- -- -- 0.12x 0.07x 0.01x 0.05x -- -- --
Operating Income Growth (YoY) -- -- -174.5% -- -431.7% -- -- -- -- --
Net Income Growth (YoY) -- -- -169.8% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -60.5% -57.1% -50.5% -54.2% -45.0% -30.5% -22.2% -19.1%
Return on Assets (ROA) -56.2% -53.3% -47.0% -50.5% -42.1% -29.7% -21.6% -18.2%
Current Ratio 14.01x 15.07x 14.52x 14.56x 15.58x 41.89x 40.48x 20.60x
Quick Ratio 13.61x 14.62x 14.00x 13.64x 15.06x 41.75x 40.25x 20.22x
Source: SEC EDGAR CompanyFacts (CIK 0000034956) · from July 31, 2010 Data through September 30, 2026 · synced Nov 20, 2026, 05:53 UTC · Open in terminal